tiprankstipranks
Advertisement
Advertisement

NNVC Stock Latest News

NanoViricides gets National Ethics Committee approval for Phase II NV-387 trial
The FlyNanoViricides gets National Ethics Committee approval for Phase II NV-387 trial
2d ago
NNVC
NanoViricides initiated with an Outperform at Noble Capital
PremiumThe Fly
NanoViricides initiated with an Outperform at Noble Capital
9d ago
NNVC
NanoViricides advances towards Phase II clinical trial of NV-387
PremiumThe Fly
NanoViricides advances towards Phase II clinical trial of NV-387
9d ago
NNVC
NanoViricides granted Rare Pediatric Disease Drug designation for NV-387
PremiumThe Fly
NanoViricides granted Rare Pediatric Disease Drug designation for NV-387
16d ago
NNVC
CDC raises Ebola Congo outbreak response to highest level, Reuters reports
PremiumThe Fly
CDC raises Ebola Congo outbreak response to highest level, Reuters reports
18d ago
CODX
GOVX
NanoViricides ships NV-387 oral gummies for Phase II trials to DR Congo
PremiumThe FlyNanoViricides ships NV-387 oral gummies for Phase II trials to DR Congo
23d ago
NNVC
NanoViricides files to sell 1.33M shares of common stock for holders
Premium
The Fly
NanoViricides files to sell 1.33M shares of common stock for holders
29d ago
NNVC
NanoViricides announces proposal approved by Pillar Committee in DRC
Premium
The Fly
NanoViricides announces proposal approved by Pillar Committee in DRC
30d ago
NNVC
NanoViricides proposes Phase II trial of NV-387 gummies in Ebola
PremiumThe Fly
NanoViricides proposes Phase II trial of NV-387 gummies in Ebola
1M ago
NNVC
NanoViricides files $50M mixed securities shelf
PremiumThe Fly
NanoViricides files $50M mixed securities shelf
1M ago
NNVC
NanoViricides says NV-387 ready to be shipped to DRC for ebola
PremiumThe Fly
NanoViricides says NV-387 ready to be shipped to DRC for ebola
2M ago
NNVC
NanoViricides Highlights NV-387 Strategy for Ebola Outbreak
PremiumCompany Announcements
NanoViricides Highlights NV-387 Strategy for Ebola Outbreak
2M ago
8K
NNVC
NanoViricides Completes $2 Million Registered Direct Offering
PremiumCompany AnnouncementsNanoViricides Completes $2 Million Registered Direct Offering
2M ago
8K
NNVC
NanoViricides emphasizes need for Ebolavirus antiviral drug
Premium
The Fly
NanoViricides emphasizes need for Ebolavirus antiviral drug
2M ago
NNVC
NanoViricides prices $2M registered direct offering
Premium
The Fly
NanoViricides prices $2M registered direct offering
2M ago
NNVC
NanoViricides reports Q1 EPS (9c) vs. (14c) last year
PremiumThe Fly
NanoViricides reports Q1 EPS (9c) vs. (14c) last year
2M ago
NNVC
NanoViricides says hantavirus incident highlights need for antiviral drugs
PremiumThe Fly
NanoViricides says hantavirus incident highlights need for antiviral drugs
2M ago
NNVC
NanoViricides announces NV-387 granted ODD by U.S. FDA OOPD
PremiumThe Fly
NanoViricides announces NV-387 granted ODD by U.S. FDA OOPD
2M ago
NNVC
NanoViricides measles virus treatment granted FDA orphan status
PremiumThe Fly
NanoViricides measles virus treatment granted FDA orphan status
3M ago
NNVC
NanoViricides says NV-387 can help control spread of measles
PremiumThe FlyNanoViricides says NV-387 can help control spread of measles
3M ago
NNVC
NanoViricides files application for RPDD for NV-387 with U.S. OPDD
Premium
The Fly
NanoViricides files application for RPDD for NV-387 with U.S. OPDD
3M ago
NNVC
NanoViricides plans to commence Phase II trial of NV-387 for Monkeypox
Premium
The Fly
NanoViricides plans to commence Phase II trial of NV-387 for Monkeypox
3M ago
NNVC

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >